HaloPV Platform by Qinecsa

HaloPV is a cloud-native, modular, full-lifecycle pharmacovigilance platform developed by Qinecsa, designed to automate and manage complex pharmacovigilance processes that sit outside core safety databases. It serves pharmaceutical companies, biotechs, and health authorities that need structured oversight of the broader PV ecosystem beyond standard case processing. The platform is built to integrate with existing infrastructure with low disruption, offering a flexible expansion path as regulatory demands and operational complexity grow.

Rather than replacing a safety database, HaloPV addresses the surrounding governance and coordination activities that are frequently the source of compliance gaps and inspection findings. It brings standardization, visibility, and traceability to high-effort, fragmented processes, helping organizations reduce manual errors, improve auditability, and maintain inspection readiness across all pharmacovigilance activities.

Core Capabilities and Modules

• PSMF management: Supports the creation, maintenance, and oversight of the Pharmacovigilance System Master File to ensure documentation remains current and audit-ready.
• Periodic report scheduling, authoring, and coordination: Manages the end-to-end workflow for periodic safety reports including PSURs and PBRERs, coordinating timelines and authoring activities across teams.
• Local safety ICSR management: Handles Individual Case Safety Report management at the local level, supporting consistent global and local PV processes.
• Vendor selection, agreement coordination, and oversight: Provides structured management of vendor relationships, including selection processes, agreement tracking, and ongoing performance oversight.

Compliance and Operational Benefits

• Reduces manual errors and process variability across PV activities.
• Improves documentation, traceability, and auditability to support regulatory inspections.
• Strengthens oversight of vendors and partners involved in pharmacovigilance operations.
• Streamlines reporting coordination and helps organizations meet submission timelines.
• Supports compliance with evolving EU and US regulatory frameworks.
• Enhances inspection readiness across the full scope of PV activities, not only within the safety database.

Deployment and Architecture

• Delivered as a cloud-native platform, enabling scalability without significant infrastructure investment.
• Modular design allows organizations to adopt specific capabilities and expand over time along a proven path.
• Designed for low-level disruption to existing safety systems and PV infrastructure during implementation.
• Operates as a technology-enabled service, combining platform functionality with Qinecsa's pharmacovigilance expertise.

HaloPV is positioned for organizations looking to scale their pharmacovigilance operations efficiently while maintaining control over the governance activities that carry the highest compliance risk, particularly as regulatory expectations across major markets continue to evolve.